Member Info for stu485

Eureka,

Within your response to a question of you having insider information, you’ve just confirmed the company advised you of;

Paraphrasing

“a company expectation of significant new sales”

Could you please highlight any RNS communication where the same “expectation” has been stated ?

I for one would consider that information as potentially material and therefore price sensitive.

Re-read your statement very carefully and you’ll realize what you’ve actually said.

Would you like to re-confirm the company have advised you as you claim, or maybe you may have misunderstood?

Look forward to your post to properly clarify.

“ So, to clarify, "looking to get" does neither imply "significant sales" which you refer to nor, from my understanding, is it a given. It is a company expectation which hopefully will materialize!”

AIMO

Lionel,

Law.

Helping the blind to see .

GL

Lionel,

…it’s still a dead horse!

Let me guess,… no it isn’t 😉

Read Joey’s post and you might finally understand.

AIMO

Joey,

Yes, at last someone sees the wood from the trees!

The worldwide market might be sufficient to attract much bigger fish,

GLA

AIMO

Lionel,

I’m sorry but you are incorrect.

I have considered the benefits of POC in my own evaluation of the sales opportunity.For the sake of argument let’s consider my understanding irrelevant and inaccurate .

So a final question to you Lionel.

Are you trying to convince me and others that the NICE experts have not considered the POC benefits when making their recommendations for Lab testing as the preferred option?

NICE are fully aware of the pros&cons of all the various tests and have clearly stated the National preference for the NHS, “Lab testing”.

This is getting very Pythonesque,… argument/repetition!

To leave on a positive note, should you and others really want to influence sentiment on here, stop flogging the obviously dead horse argument and move onto an aspect where you might actually have some validity;

…a potential takeover offer !

AIMO

Lionel,

I don’t think you read the entire article and links ?

NICE:

“This means that tests that only identify the most common alleles may disproportionately fail to identify people with loss-of-function alleles in these groups.

Laboratory-based testing could identify a wider range of alleles than point-of-care tests.

It can also be changed more easily to test for other pharmacogenomic markers if needed.

Centralised laboratory testing would also provide more consistency across the NHS.

So, laboratory tests should be used if possible.”

-Accuracy

-Adaptability

-Consistency

All benefits of Lab testing over POC according to the NICE experts.

I agree it is an informative article and further outlines the extent of opportunity for POC tests in the NHS.

AIMO

Sharedealer,

No i do not believe there's any Libel where Slacker's posts are concerned.

I would again advise, you err on the side of caution with regards to your posts for the reasons perviously advised.

AIMO

Sharedealer,

If you understood the law as you claim, you’d understand the risks you’re running with your particular posts regarding Slacker.

I and you will know if you truly understand from future posts .

AIMO

Eureka,

I have already accepted there is a window of opportunity for GD POC test sales, while the Lab capacity is expanded.

No potential sales forecast from the company and NICE recommend to monitor GD’s accuracy ( but not others) are both Red flags to me and tell me all i need to know on the potential.

No point me posting further until next RNS.

GLA

AIMO

Sharedealer,

“ Slacker will say again ALL of your messages on here are being monitored by the GDR legal team for use in their libel case against you! The amount you lost here and seem bitter about, will be insignificant to how much they will be coming after you for! ”

It’s clear you do not understand law and grounds for Libel.

You are though correct in that the board is monitored.

Were there to be instances of deliberate and determined deformation of character in an attempt to manipulate a share price , it might become apparent.

It has been before and those involved are still to endure the full ramifications.

Just a friendly note of caution.

AIMO

No sorry, mine is the short answer to your more convoluted question.

“Forecast sales” not “how to achieve a forecast sale’s pipeline”

The company silence is a deafening answer!

No pun intended

AIMO

Gloria,

They have already answered the question, you’re simply choosing to ignore the answer.

No RNS on forecast near term sales potential, says all you need to know !

AIMO

Gloria,

This the type of question, you have in mind?

“Dear GD,

Can you please convince clinicians to ignore the expert NICE advice and use POC rather than LAB test, routinely rather than exceptionally!”

…are we realizing the problem yet !?

AIMO

While the national LAB test capacity is expanded to the NICE recommendations, there’s a window of opportunity for POC test within the NHS.

What’s that sales potential for GD ?

Many amateurs speculating on here with estimates ranging from nothing to many millions.

Rather than trying to make sense of the differing noise on here, why not get the truth from the party best placed to actually know it,… the company !?

So, what is their estimate on forecast sales ?

….silence !

Now consider, were the company aware of a near term potential sales forecast of a value triggering material benefit, they would need to advise the market.

…any such advice been announced?

It’s very simple if you filter the noise and only consider company RNS’s.

AIMO

……LAB testing !!!!

Carrots,

You’d be much more effective in your objective by highlighting a positive rather than keep shining a light on the FACT , (regardless of all the apparent advantages you claim),

NICE have deliberated on all the pros&cons

and recommended LAB testing as the national preference!!!

Your highlighting a rather significant Negative !

AIMO

Carrot ?

You busy phoning a friend for an answer?

Some advice, If you’re going to incessantly ramp , best be prepared to back up your claims in future !

No one’s buying that drivel but I’m sure you’ll continue.

AIMO

Carrot,

With all the “apparent “ advantages you repeatedly pronounce, why would the professional body to asses such aspects recommend Lab testing as the national preference over GD POC ?

Look forward to your answer.

AIMO

Gloria,

Nope not at my table but I’m not dining in the GD restaurant!

Have a good evening.

Gloria,

Unsurprisingly you haven’t managed to post a clinician’s statements confirming an intent, (implied or otherwise),to use POC over LAB testing.

The statement you’re highlighting, is confirmation of what we already know from the NICE RNS , that being, some will/may now use POC when Lab testing is unavailable.

To this extent we agree so let’s move onto the bigger question.

Q. What’s the potential sales opportunity for GD ?

Well, we don’t know !

Why? because the company has chosen not to offer any information on potential sales forecast.

Ironically, this fact In itself offers insight as to the potential sales opportunity.

Consider the company is obligated to advise of

any news with potential or actual material impact.

Anticipating new POC test sales of a magnitude for material impact would require market notification of the same.

With no such notification we can conclude new sales of this particular POC product are not anticipated to be material, within the near term.

You have already suggested you’re not particularly optimistic for significant sales of GD POC within the UK, on this point we further agree.

I do expect some further POC test sales but insufficient to address the cash-burn rate.

My conclusions based on objective reasoning and not assumptions as yours.

GLA

AIMO

Gloria,

I have no intention of spending my day posting here, so for the sake of expedience would it not be quicker for you to post a statement from any clinician advising he/she intends to use POC in preference to an available LAB test.

Please note the statement you’ve highlighted so far most definitely do not !

I’ll check back in later this evening and look forward to reading.

AIMO